Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a ...

The ranibizumab injection could be administered in a convenient schedule twice per year for the treatment of diabetic macular ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.

The FDA approved Susvimo for the treatment of diabetic macular edema, according to a press release. The decision was supported by positive 1-year data from the phase 3 Pagoda study, in which Susvimo ...

Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone shots for people with a rare genetic form of lipodystrophy that leaves patients ...

Examples include headache, injection site reactions ... A boxed warning is the most serious warning from the Food and Drug Administration (FDA). For details, see the “Side effect specifics ...

When giving gluteal injections, it is safest to use the ... Medical treatments including administration of vitamins and alphachymotrypsine have been tried with varying results, depending on ...

Bristol-Myers Squibb has won FDA approval for the first LAG-3 inhibitor drug ahead of its rivals in cancer immunotherapy, including Merck & Co. The US regulator cleared BMS' LAG-3 drug relatlimab ...

He serves with Vice President J.D. Vance (R), a former senator from Ohio. This page provides an overview of Trump's second presidential administration, including top officials and personnel and key ...